Inventurus Knowledge Solutions Ltd IPO

We are a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. We offer a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Our offerings include, Revenue Optimization Solutions, that enable healthcare organizations to generate, capture and optimize their revenue, improve operational efficiencies, and increase enterprise value through a cost-optimized, globalized, technologyenabled offering with on-demand scalability. Our Revenue Optimization Solutions are offered in the Pre-Visit Stage and include patient scheduling services and IKS EVE, at the Peri-Visit Stage and include clinical coding solutions and referral order management, at the Post Visit Stage that include Billing, Payment Posting, Denial Management, and Account Receivables Follow Up, IKS Optimix and at the In-Acute Settings Stage. We provide Clinical Support Solutions at each stage that include IKS Scribble, IKS Stacks, IKS AssuRx and IKS Migrate. In addition, we also provide clinical chart review and Hierarchical Condition Codes (HCC) coding solutions which cater to our Value Based Care (VBC) portfolio. Our Unifying Data Platform solution enables healthcare organizations to ingest, aggregate, normalize, sort and clean clinical, financial and administrative data for a provider enterprise into a single enterprise data warehouse. We generate revenue from the sale of our services and offerings to clients. As of September 30, 2024, we served 778 US-based healthcare organizations. As of September 30, 2024.

Open Demat Account

50years

Inventurus Knowledge Solutions Ltd IPO Details

Details

Total Shares OfferedOffer to PublicRetail Max (Shares)Pre Issue Promoters HoldingExchangeIssue size
₹ 187.96 L₹ 187.96 L₹ 18.73 L₹ 1,196.43 LBSE₹ 2497.92 Cr
IPO Open DateClose DateLot SizeMin InvestmentIssue TypeListing Date
12 Dec, 2416 Dec, 2411 ₹ 13,915 Book Building19 Dec, 24

Inventurus Knowledge Solutions Ltd IPO Dates

  • 12 Dec 2024

    Opening date

  • 16 Dec 2024

    Closing date

  • 17 Dec 2024

    Basis of
    Allotment

  • 18 Dec 2024

    Initiation of
    Refunds

  • 18 Dec 2024

    Credit of
    Shares

  • 19 Dec 2024

    Listing date

Details

SectorType
SectorComputers - Software - Medium
Sub SectorSmall
Issue TypeBook Building

Subscription Status

*Values are in Lakhs

Investor TypeSubscription TimesShares Offered*Shares Bid*
QIB0.62x140478838677757
NII0.79x28095762211396
Retail1.68x18730513145505
Employee0.8x6500052239
Total0.75x1879551014086897

Subscription Status

Investor Type

QIB

NII

Retail

Employee

Total

*Values are in Lakhs

Inventurus Knowledge Solutions Ltd Financial Status

Income Statement

Balance Sheet

Particulars (in Rs. Crores)FY23FY22FY21
Revenue from operations1,817.931,031.30763.63
EBITDA432.97327.10244.83
PAT336.91253.48188.88
Total Assets557.73670.13467.81
Share Capital16.9216.8416.81
Total Borrowings292.41109.1093.70
Operating Activities (Net Cash)358.54273.15207.54
Investing Activities (Net Cash)472.9218.7616.31
Financing Activities (Net Cash)292.41109.1093.70
Net Cashflow205.43494.74336.47

Particulars (in Rs. Crores)

Revenue from operations

EBITDA

PAT

Total Assets

Share Capital

Total Borrowings

Operating Activities (Net Cash)

Investing Activities (Net Cash)

Financing Activities (Net Cash)

Net Cashflow

About Inventurus Knowledge Solutions Ltd

Our Company was incorporated as Inventurus Knowledge Solutions Private Limited under the Companies Act, 1956 at Goa, pursuant to a certificate of incorporation dated September 5, 2006, issued by the Registrar of Companies, Goa, Daman and Diu at Goa. The registered office of our Company was shifted from Panduronga Timblo Industries, Akash Bhavan, 2nd Floor, Opp. Canara Bank, Panjim, Goa, India to Building No. 5 & 6, Unit No. 801, 8th Floor, Mindspace SEZ, Thane Belapur Road, Airoli, Navi Mumbai, Thane, Maharashtra, India - 400 708, with effect from January 1, 2020. On the conversion of our Company to a public limited company, pursuant to a resolution passed by Board on October 14, 2022 and our Shareholders on October 17, 2022, the name of our Company was changed to Inventurus Knowledge Solutions Limited, consequent to which a fresh certificate of incorporation dated November 4, 2022 was issued by the Registrar of Companies, Maharashtra at Mumbai (RoC).

As per the Zinnov Report, the outsourced services market in the technology -enabled healthcare provider space is growing rapidly as providers seek to boost efficiency and streamline operations. By leveraging technologyenabled service providers to handle workflows like billing, revenue cycle management, patient engagement, and data analytics, healthcare organizations can focus on core patient care activities and achieve higher quality care while maintaining operational excellence.

We are a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. We offer a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Our offerings include, Revenue Optimization Solutions, that enable healthcare organizations to generate, capture and optimize their revenue, improve operational efficiencies, and increase enterprise value through a cost-optimized, globalized, technologyenabled offering with on-demand scalability. Our Revenue Optimization Solutions are offered in the Pre-Visit Stage and include patient scheduling services and IKS EVE, at the Peri-Visit Stage and include clinical coding solutions and referral order management, at the Post Visit Stage that include Billing, Payment Posting, Denial Management, and Account Receivables Follow Up, IKS Optimix and at the In-Acute Settings Stage. We provide Clinical Support Solutions at each stage that include IKS Scribble, IKS Stacks, IKS AssuRx and IKS Migrate. In addition, we also provide clinical chart review and Hierarchical Condition Codes (HCC) coding solutions which cater to our Value Based Care (VBC) portfolio. Our Unifying Data Platform solution enables healthcare organizations to ingest, aggregate, normalize, sort and clean clinical, financial and administrative data for a provider enterprise into a single enterprise data warehouse. We generate revenue from the sale of our services and offerings to clients. As of September 30, 2024, we served 778 US-based healthcare organizations. As of September 30, 2024.

Peer Comparison:

  • No Listed Industry Peers

Inventurus Knowledge Solutions Ltd IPO Key Points

Strengths

  • Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations.
  • Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.
  • Strong brand driven by clinical thought leadership through IKS Advisory Board, a healthcare industry leadership forum, and partnerships with industry players and evident through multiple awards and recognitions.
  • Marquee large enterprise clientele that include academic medical centres and healthcare systems, multispecialty and single-specialty medical groups, ancillary healthcare organizations, value enablers, and other outpatient healthcare delivery organizations and client stickiness reflected in revenues from repeat clients of over 98% in the last three Fiscals.
  • Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch engagement through access to project executive sponsors and leadership teams creating cross-selling opportunities.

Risk

  • There have been certain FEMA related deficiencies in compliances in the past by the Company and some of its existing and erstwhile shareholders, with respect to issuance of securities of the Company, delays in relation to reporting requirements and transfer of securities of the Company. The company has filed compounding applications with the RBI in respect of such contraventions, which are currently pending. Consequently, its may be subject to regulatory actions and penalties/ compounding fees, as applicable.
  • The company has outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.
  • If the company fails to successfully develop and introduce new solutions based on artificial intelligence and machine learning technologies and features to existing solutions such as AI-powered speech-to-text solutions, its revenues, operating results and reputation could suffer.

Strategy

  • Maximise revenue from existing clients through a land and expand approach.
  • Focus on large healthcare organizations.
  • Move from a human-led tech-enabled model to a tech-led human-enabled model.
  • Bundling our solutions for greater value-add.
  • Leverage automation and Generative Artificial Intelligence (AI) to aid our operations.
  • Comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations.
  • Leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.
  • Strong brand driven by clinical thought leadership through IKS Advisory Board, a healthcare industry leadership forum, and partnerships with industry players and evident through multiple awards and recognitions.
  • Marquee large enterprise clientele that include academic medical centres and healthcare systems, multispecialty and single-specialty medical groups, ancillary healthcare organizations, value enablers, and other outpatient healthcare delivery organizations and client stickiness reflected in revenues from repeat clients of over 98% in the last three Fiscals.
  • Sustainable and scalable business model offering clients flexibility and cost-savings and high-touch engagement through access to project executive sponsors and leadership teams creating cross-selling opportunities.

How To Apply for Inventurus Knowledge Solutions Ltd IPO Online?

Step 1:

Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

Get your FAQs right

Inventurus Knowledge Solutions Ltd's IPO offers shares for up to NA It begins on Dec 12, 2024 and ends on Dec 16, 2024.

The price of Inventurus Knowledge Solutions Ltd IPO ranges between ₹1265 to ₹1329 per share.

The Inventurus Knowledge Solutions Ltd IPO opens on Dec 12, 2024 and closes on Dec 16, 2024.

The allotment for the Inventurus Knowledge Solutions Ltd IPO will be finalised on Dec 17, 2024. The shares will be listed on BSE and NSE on Dec 19, 2024.

The minimum lot size for Inventurus Knowledge Solutions Ltd IPO is 11 shares, priced between ₹1265 to ₹1329 per share.

The GMP (Grey Market Premium) of Inventurus Knowledge Solutions Ltd IPO fluctuates based on market demand and sentiment.

To check the allotment status of Inventurus Knowledge Solutions Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

The Inventurus Knowledge Solutions Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Dec 12, 2024, and closes on Dec 16, 2024. The allotment is finalised on Dec 17, 2024.

To apply for the Inventurus Knowledge Solutions Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.